文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

图像引导放疗降低高危前列腺癌包膜外病变剂量不足风险并改善生化控制

Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control.
PubMed 文献 · Radiat Oncol · 2018-04-12

该研究对比IMRT与IG-IMRT治疗高危前列腺癌患者,通过计算机模拟摆位误差评估前列腺及包膜外高危区域累积剂量的不确定性,并采用多因素Cox回归分析PRFS相关因素。结果显示两组计划剂量学相似,但IG-IMRT显著降低包膜外区域剂量不确定性,包膜外病变风险与低剂量风险的交互项及临床危险因素数量与PRFS降低相关。

要点

  • IG-IMRT较IMRT显著降低包膜外病变区域剂量不确定性。
  • 包膜外病变风险与低剂量风险的交互项与PRFS降低相关(p=0.005)。
  • 临床危险因素数量与PRFS降低相关(p=0.008)。

核心结论

  • IG-IMRT相比无IG的IMRT改善高危前列腺癌PSA结局可能源于包膜外病变剂量学的改善。

研究设计与样本

  • 回顾性分析连续接受IMRT(n=67)和IG-IMRT(n=35)的高危前列腺癌患者计划数据,利用计算机模拟摆位误差估计患者特异性累积剂量分布不确定性。
  • 采用多因素Cox回归分析PRFS,考虑Gleason评分、T分期、治疗前PSA、临床危险因素数量、列线图预测的包膜外病变风险及剂量指标。

主要发现

  • IMRT与IG-IMRT的计划剂量学值相似,但模拟显示因摆位不确定性导致前列腺外部递送剂量的不确定性显著不同。
  • 包膜外病变风险与包膜外病变低剂量风险的交互项(p=0.005)及临床危险因素数量(p=0.008)与PRFS降低相关。

临床怎么用

  • 高危前列腺癌IMRT应配合每日图像引导以减少摆位不确定性,改善包膜外病变区域剂量覆盖。

局限性

  • 样本量较小(IMRT组67例,IG-IMRT组35例),为回顾性分析,剂量不确定性基于计算机模拟而非实际测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To determine if reduced dose delivery uncertainty is associated with daily image-guidance (IG) and Prostate Specific Antigen Relapse Free Survival (PRFS) in intensity-modulated radiotherapy (IMRT) of high-risk prostate cancer (PCa). METHODS: Planning data for consecutive PCa patients treated with IMRT (n = 67) and IG-IMRT (n = 35) was retrieved. Using computer simulations of setup errors, we estimated the patient-specific uncertainty in accumulated treatment dose distributions for the prostate and for posterolateral aspects of the gland that are at highest risk for extra-capsular disease. Multivariate Cox regression for PRFS considering Gleason score, T-stage, pre-treatment PSA, number of elevated clinical risk factors (T2c+, GS7+ and PSA10+), nomogram-predicted risk of extra-capsular disease (ECD), and dose metrics was performed. RESULTS: For IMRT vs. IG-IMRT, plan dosimetry values were similar, but simulations revealed uncertainty in delivered dose external to the prostate was significantly different, due to positioning uncertainties. A patient-specific interaction term of the risk of ECD and risk of low dose to the ECD (p = 0.005), and the number of elevated clinical risk factors (p = 0.008), correlate with reduced PRFS. CONCLUSIONS: Improvements in PSA outcomes for high-risk PCa using IG-IMRT vs. IMRT without IG may be due to improved dosimetry for ECD.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Munck Af Rosenschold P, Zelefsky MJ, Apte AP, et al. Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control. Radiat Oncol. 2018. PMID: 29650035. doi:10.1186/s13014-018-0978-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。